Logo image of SREA

SEMPRA - SRE 5 3/4 07/01/2079 (SREA) Stock Fundamental Analysis

USA - NYSE:SREA - US8168516040

23.02 USD
-0.09 (-0.39%)
Last: 9/17/2025, 12:46:50 PM
Fundamental Rating

3

SREA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 25 industry peers in the Multi-Utilities industry. While SREA is still in line with the averages on profitability rating, there are concerns on its financial health. SREA is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year SREA was profitable.
SREA had a positive operating cash flow in the past year.
In the past 5 years SREA has always been profitable.
In the past 5 years SREA always reported a positive cash flow from operatings.
SREA Yearly Net Income VS EBIT VS OCF VS FCFSREA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B

1.2 Ratios

With a Return On Assets value of 2.67%, SREA perfoms like the industry average, outperforming 44.00% of the companies in the same industry.
The Return On Equity of SREA (8.42%) is comparable to the rest of the industry.
The Return On Invested Capital of SREA (2.77%) is worse than 92.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SREA is in line with the industry average of 3.82%.
Industry RankSector Rank
ROA 2.67%
ROE 8.42%
ROIC 2.77%
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
SREA Yearly ROA, ROE, ROICSREA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

SREA has a Profit Margin of 20.02%. This is amongst the best in the industry. SREA outperforms 100.00% of its industry peers.
SREA's Profit Margin has improved in the last couple of years.
SREA has a better Operating Margin (22.76%) than 72.00% of its industry peers.
SREA's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 22.76%
PM (TTM) 20.02%
GM N/A
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
SREA Yearly Profit, Operating, Gross MarginsSREA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

1

2. Health

2.1 Basic Checks

SREA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SREA has been increased compared to 1 year ago.
Compared to 5 years ago, SREA has more shares outstanding
Compared to 1 year ago, SREA has a worse debt to assets ratio.
SREA Yearly Shares OutstandingSREA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SREA Yearly Total Debt VS Total AssetsSREA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

Based on the Altman-Z score of 0.56, we must say that SREA is in the distress zone and has some risk of bankruptcy.
SREA has a worse Altman-Z score (0.56) than 88.00% of its industry peers.
A Debt/Equity ratio of 1.17 is on the high side and indicates that SREA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.17, SREA belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACC0.58
WACC4.82%
SREA Yearly LT Debt VS Equity VS FCFSREA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

A Current Ratio of 0.48 indicates that SREA may have some problems paying its short term obligations.
SREA's Current ratio of 0.48 is on the low side compared to the rest of the industry. SREA is outperformed by 92.00% of its industry peers.
A Quick Ratio of 0.41 indicates that SREA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.41, SREA is doing worse than 88.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.48
Quick Ratio 0.41
SREA Yearly Current Assets VS Current LiabilitesSREA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

3

3. Growth

3.1 Past

SREA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.31%.
SREA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.31% yearly.
SREA shows a decrease in Revenue. In the last year, the revenue decreased by -1.04%.
The Revenue has been growing slightly by 4.04% on average over the past years.
EPS 1Y (TTM)6.31%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%0%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%-0.37%

3.2 Future

Based on estimates for the next years, SREA will show a small growth in Earnings Per Share. The EPS will grow by 7.04% on average per year.
SREA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.62% yearly.
EPS Next Y-1.2%
EPS Next 2Y4.82%
EPS Next 3Y6.01%
EPS Next 5Y7.04%
Revenue Next Year-9.66%
Revenue Next 2Y-2.27%
Revenue Next 3Y-0.3%
Revenue Next 5Y2.62%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SREA Yearly Revenue VS EstimatesSREA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
SREA Yearly EPS VS EstimatesSREA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.88, the valuation of SREA can be described as very cheap.
SREA's Price/Earnings ratio is rather cheap when compared to the industry. SREA is cheaper than 88.00% of the companies in the same industry.
SREA is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
SREA is valuated cheaply with a Price/Forward Earnings ratio of 4.54.
Based on the Price/Forward Earnings ratio, SREA is valued cheaper than 88.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SREA to the average of the S&P500 Index (22.71), we can say SREA is valued rather cheaply.
Industry RankSector Rank
PE 4.88
Fwd PE 4.54
SREA Price Earnings VS Forward Price EarningsSREA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SREA is valued a bit cheaper than 68.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.2
SREA Per share dataSREA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.82%
EPS Next 3Y6.01%

3

5. Dividend

5.1 Amount

SREA has a Yearly Dividend Yield of 3.09%. Purely for dividend investing, there may be better candidates out there.
SREA's Dividend Yield is slightly below the industry average, which is at 3.64.
Compared to an average S&P500 Dividend Yield of 2.38, SREA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.09%

5.2 History

The dividend of SREA decreases each year by -9.71%.
SREA has been paying a dividend for over 5 years, so it has already some track record.
SREA has decreased its dividend recently.
Dividend Growth(5Y)-9.71%
Div Incr Years0
Div Non Decr Years1
SREA Yearly Dividends per shareSREA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

SREA pays out 59.51% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP59.51%
EPS Next 2Y4.82%
EPS Next 3Y6.01%
SREA Yearly Income VS Free CF VS DividendSREA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B
SREA Dividend Payout.SREA Dividend Payout, showing the Payout Ratio.SREA Dividend Payout.PayoutRetained Earnings

SEMPRA - SRE 5 3/4 07/01/2079

NYSE:SREA (9/17/2025, 12:46:50 PM)

23.02

-0.09 (-0.39%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners95.23%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap15.02B
Analysts74
Price Target24.21 (5.17%)
Short Float %0.01%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield 3.09%
Yearly Dividend2.41
Dividend Growth(5Y)-9.71%
DP59.51%
Div Incr Years0
Div Non Decr Years1
Ex-Date09-15 2025-09-15 (0.359375)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.09%
Min EPS beat(2)4.16%
Max EPS beat(2)8.03%
EPS beat(4)2
Avg EPS beat(4)-2.82%
Min EPS beat(4)-16.27%
Max EPS beat(4)8.03%
EPS beat(8)4
Avg EPS beat(8)-1.5%
EPS beat(12)8
Avg EPS beat(12)1.82%
EPS beat(16)11
Avg EPS beat(16)2.7%
Revenue beat(2)0
Avg Revenue beat(2)-3.99%
Min Revenue beat(2)-4.09%
Max Revenue beat(2)-3.89%
Revenue beat(4)0
Avg Revenue beat(4)-11.25%
Min Revenue beat(4)-22.35%
Max Revenue beat(4)-3.89%
Revenue beat(8)0
Avg Revenue beat(8)-15%
Revenue beat(12)2
Avg Revenue beat(12)-5.44%
Revenue beat(16)6
Avg Revenue beat(16)-1.39%
PT rev (1m)6.78%
PT rev (3m)8.44%
EPS NQ rev (1m)3.09%
EPS NQ rev (3m)0.17%
EPS NY rev (1m)0.03%
EPS NY rev (3m)-0.12%
Revenue NQ rev (1m)2.75%
Revenue NQ rev (3m)-3.75%
Revenue NY rev (1m)-2.01%
Revenue NY rev (3m)-2.76%
Valuation
Industry RankSector Rank
PE 4.88
Fwd PE 4.54
P/S 1.13
P/FCF N/A
P/OCF 3.23
P/B 0.47
P/tB 0.5
EV/EBITDA 9.2
EPS(TTM)4.72
EY20.5%
EPS(NY)5.08
Fwd EY22.05%
FCF(TTM)-8.26
FCFYN/A
OCF(TTM)7.13
OCFY30.97%
SpS20.44
BVpS48.61
TBVpS45.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.67%
ROE 8.42%
ROCE 3.32%
ROIC 2.77%
ROICexc 2.78%
ROICexgc 2.83%
OM 22.76%
PM (TTM) 20.02%
GM N/A
FCFM N/A
ROA(3y)3.02%
ROA(5y)3.29%
ROE(3y)9.1%
ROE(5y)9.64%
ROIC(3y)3.3%
ROIC(5y)3.52%
ROICexc(3y)3.32%
ROICexc(5y)3.56%
ROICexgc(3y)3.41%
ROICexgc(5y)3.66%
ROCE(3y)3.99%
ROCE(5y)4.26%
ROICexcg growth 3Y-8.37%
ROICexcg growth 5Y-5.96%
ROICexc growth 3Y-8.1%
ROICexc growth 5Y-5.8%
OM growth 3Y0.45%
OM growth 5Y-2.46%
PM growth 3Y29.87%
PM growth 5Y2.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF N/A
Debt/EBITDA 6.68
Cap/Depr 396.53%
Cap/Sales 75.31%
Interest Coverage 2.3
Cash Conversion 83.55%
Profit Quality N/A
Current Ratio 0.48
Quick Ratio 0.41
Altman-Z 0.56
F-Score4
WACC4.82%
ROIC/WACC0.58
Cap/Depr(3y)359.34%
Cap/Depr(5y)353.45%
Cap/Sales(3y)54.96%
Cap/Sales(5y)53.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.31%
EPS 3Y-18.2%
EPS 5Y-5.31%
EPS Q2Q%0%
EPS Next Y-1.2%
EPS Next 2Y4.82%
EPS Next 3Y6.01%
EPS Next 5Y7.04%
Revenue 1Y (TTM)-1.04%
Revenue growth 3Y0.84%
Revenue growth 5Y4.04%
Sales Q2Q%-0.37%
Revenue Next Year-9.66%
Revenue Next 2Y-2.27%
Revenue Next 3Y-0.3%
Revenue Next 5Y2.62%
EBIT growth 1Y9.84%
EBIT growth 3Y1.29%
EBIT growth 5Y1.48%
EBIT Next Year59%
EBIT Next 3Y22.19%
EBIT Next 5Y14.33%
FCF growth 1Y-0.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.97%
OCF growth 3Y8.5%
OCF growth 5Y9.71%